CLINICAL TRIALS PROFILE FOR MAZINDOL
✉ Email this page to a colleague
All Clinical Trials for MAZINDOL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00000277 ↗ | Mazindol for Cocaine Abuse - 2 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | 1994-09-01 | The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse. |
NCT00000277 ↗ | Mazindol for Cocaine Abuse - 2 | Completed | VA Connecticut Healthcare System | Phase 2 | 1994-09-01 | The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse. |
NCT00000277 ↗ | Mazindol for Cocaine Abuse - 2 | Completed | Yale University | Phase 2 | 1994-09-01 | The purpose of this study is to evaluate high and low dose mazindol for cocaine abuse. |
NCT02808104 ↗ | Mazindol Controlled Release in Adults With Attention Deficit Hyperactivity Disorder (ADHD) | Completed | NLS Pharma Inc. | Phase 2 | 2016-08-01 | The purpose of this study is to determine whether a controlled release formulation of mazindol is more effective than a placebo in the treatment of Attention Hyperactivity Disorder (ADHD) in adults. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MAZINDOL
Condition Name
Clinical Trial Locations for MAZINDOL
Trials by Country
Clinical Trial Progress for MAZINDOL
Clinical Trial Phase
Clinical Trial Sponsors for MAZINDOL
Sponsor Name